<DOC>
	<DOC>NCT02716129</DOC>
	<brief_summary>The primary endpoint of this study is to investigate the effect of adding nalbuphine to intrathecal morphine on quality of postoperative analgesia and Morphine related side effects post- cesarean delivery.</brief_summary>
	<brief_title>The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section</brief_title>
	<detailed_description>The study will be performed in Assiut University Hospitals, after obtaining approval from the local ethics committee and written informed patient consent. All patients will have a peripheral IV cannula 18 G inserted; standard non-invasive monitors will be applied. All the patients will be preloaded with 10 ml/kg Ringer's lactate solution intravenous. Intrathecal block under strict aseptic conditions will be performed in sitting position at L3-4 or L4-5 inter-spinous space with 25G pencil-point spinal needle. All patients will receive intrathecal 10 mg of 0.5% hyperbaric bupivacaine.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Nalbuphine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Female patients age between 16 to 40 years ASA physical status I II Infection at the site of injection. Coagulopathy or other bleeding diathesis. Preexisting neurologic deficits. History of hypersensitivity to any of the given the drugs. Inability to communicate with the investigator and the hospital staff. History of chronic opioid us</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>